25 of the Best Hematologists Near Me

Ajithkumar Puthillath is a Hematologist and an Oncologist practicing medicine in Lodi, California. Dr. Puthillath is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Anemia, ALK-Positive Non-Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma, and Thrombocytopenia. Dr. Puthillath is board certified in Internal Medicine (Sub: Medical Oncology). Dr. Puthillath is currently accepting new patients.

Min Sun, MD, PhD, is an oncologist and hematologist at UPMC. He specializes in the clinical care of breast cancer patients and those at high-risk for breast cancer. He also researches breast cancer tumor markers and early diagnosis. Dr. Sun is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Hepatectomy, and Nephrectomy. Dr. Sun is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Sun is currently accepting new patients.

Vikas Gupta is a Hematologist Oncology provider practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 17 years. Dr. Gupta is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Cutaneous T-Cell Lymphoma (CTCL), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Gupta is board certified in American Board Of Internal Medicine, 2015. Dr. Gupta is currently accepting new patients.

Dr. Alexander J. Ambinder is an instructor of medicine at the Johns Hopkins University School of Medicine. He is active in the Division of Hematology Malignancies, Leukemia Program at the Sidney Kimmel Comprehensive Cancer at Johns Hopkins. Dr. Ambinder has expertise in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and bone marrow transplantation. Dr. Ambinder received his B.A. from Washington University in St. Louis. He earned his M.D. from Emory University School of Medicine and his M.P.H. from Emory University Rollins School of Public Health. He completed the Osler Medical Residency Training Program in internal medicine at Johns Hopkins and subsequently served as an Assistant Chief of Service (Chief Resident). He completed his fellowships in Hematology and Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and also served as a Chief Fellow. Dr. Ambinder is a member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Ambinder’s principle research interest is in designing and conducting clinical trials inspired by laboratory insights to improve the management of acute myeloid leukemia and myelodysplastic syndrome. He also has an interest in building large databases that will yield insights that allow for more personalized approaches to the care and treatment of patients with blood cancers. Dr. Ambinder is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Childhood Acute Myeloid Leukemia, and Bone Marrow Aspiration. Dr. Ambinder is board certified in American Board Of Internal Medicine. Dr. Ambinder is currently accepting new patients.

Bradley Goldberg, MD, is an attending physician based at the Monter Cancer Center where he specializes in treating patients with both benign and malignant hematologic conditions. Board certified in Internal Medicine, Hematology, and Medical Oncology, Dr. Goldberg maintains an active practice where he focuses on compassionate, personalized, and evidence-based multi-disciplinary care. He is part of the team rotating through the inpatient malignant hematology service at North Shore University Hospital (located on 7 Monti). Dr. Goldberg earned his medical degree at SUNY Downstate College of Medicine. He completed his internal medicine residency and his medical oncology and hematology fellowship at the Northwell Health program located at North Shore University Hospital and Long Island Jewish Medical Center. He is currently an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Goldberg is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Acute Promyelocytic Leukemia, Childhood Acute Myeloid Leukemia, Acute Myeloblastic Leukemia with Maturation, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration. Dr. Goldberg is board certified in American Board Of Internal Medicine/Medical Oncology, American Board Of Internal Medicine, and American Board Of Internal Medicine/Hematology. Dr. Goldberg is currently accepting new patients.

Barry Paul is a Hematologist practicing medicine in Charlotte, North Carolina. Dr. Paul is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Paul is currently accepting new patients.

James Isaacs is a Hematologist and an Oncologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 14 years. Dr. Isaacs is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Melanoma, Melanoma of the Eye, Merkel Cell Carcinoma, and Metastatic Uveal Melanoma. Dr. Isaacs is board certified in American Board Of Internal Medicine, 2023. Dr. Isaacs is currently accepting new patients.

Steven R. Savona, MD, is an attending physician based at the Monter Cancer Center where his major clinical interests include blood disorders such as malignant and non-malignant hematology diseases as well as oncology expertise in the areas of diseases of the skin including melanoma, basal cell cancer and squamous cell cancer; he also sees patients with colorectal cancer and pancreas cancer. Dr. Savona maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Medical Oncology, Hematology and Hospice/Palliative medicine, Dr. Savona is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Savona is an active participant in the Cancer Control Program of the National Cancer Institute sponsored clinical trials based at Northwell. He is an investigator on cancer control studies, studies for the treatment of cancer of the pancreas as well as squamous cancer of the skin. In prior studies, Dr. Savona has addressed issues such as tobacco dependency and smoking cessation, redeveloping life styles and physical activity levels after completion of chemotherapy, the prevention of infections in patients with impaired immunity and prevention of hot flashes in patients on hormonal therapy. Dr. Savona earned his medical degree from Duke University School of Medicine. He completed both his residency in internal medicine and his fellowship in Medical Oncology/Hematology at New York University Medical Center. Dr. Savona is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Savona is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Malignant Peripheral Nerve Sheath Tumor, Bone Tumor, Melanoma, Thrombocytopenia, and Bone Marrow Aspiration. Dr. Savona is board certified in American Board Of Internal Medicine/Medical Oncology, American Board Of Internal Medicine, and American Board Of Internal Medicine/Hematology. Dr. Savona is currently accepting new patients.

William Rafelson, MD, MBA, is a fellowship-trained hematologist-oncologist with Atlantic Medical Group (AMG). Board-certified in Internal Medicine, Hematology, and Medical Oncology by the American Board of Internal Medicine, he has a focus in the management of advanced genitourinary cancers (cancers arising from the bladder, urinary tract, kidney, prostate, or testes), and treats a range of hematologic and oncologic disorders. He believes in providing compassionate care and uses a shared decision-making approach in tailoring the right treatment regimen, whether that is chemotherapy, hormone therapy, or immunotherapy to treat the patient’s disease.After earning his medical degree at the UMDNJ-Robert Wood Johnson Medical School at Camden, NJ, Dr. Rafelson completed an internal medicine residency at The Warren Alpert Medical School of Brown University, Providence, RI, served as a National Institutes of Health (NIH) T32 post-doctoral research fellow at Rhode Island Hospital, also in Providence, followed by fellowship in Hematology/Oncology, again at Warren Alpert School of Medicine. He also holds an MBA from the Heller School for Social Policy and Management, Brandeis University, Waltham, MA. Prior to joining AMG, he served as assistant attending in the Solid Tumor Genitourinary Oncology service at Memorial Sloan Kettering Cancer Center in Middletown, NJ, and served on the inpatient genitourinary service in Memorial Hospital in New York City.The author of multiple publications in peer-reviewed medical journals, Dr. Rafelson has also written several chapters in medical textbooks, including Ferri’s Clinical Advisor. He won a National Research Service Postdoctoral Award from the NIH and was one of just 15 medical oncologists nationally to be selected for a Rising Star Award from Castle Connolly. He was selected as one of “Jersey’s Best” medical oncologists in 2022 and 2023.Prior to joining AMG, Dr. Rafelson served as Instructor of Medicine and, later, Assistant Professor of Medicine at Weill Cornell Medical College, Cornell University, New York City, teaching first- and second-year medical students. He is a member of the American Society for Clinical Oncology and the American College of Physicians. He attends the MSKCC Annual Hematology-Oncology Review as well as ASCO annual conferences yearly to apply the most up-to-date information in his specialty. Dr. Rafelson is a participating provider of the Atlantic Accountable Care Organization. Dr. Rafelson is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, and Urothelial Cancer. Dr. Rafelson is board certified in American Board Of Internal Medicine. Dr. Rafelson is currently accepting new patients.

Zeyad Kanaan is a Hematologist and an Oncologist practicing medicine in Santa Rosa, California. Dr. Kanaan is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Unicentric Castleman Disease (UCD), Castleman Disease, and Multicentric Castleman Disease (MCD). Dr. Kanaan is board certified in Hematology Medical Oncology. Dr. Kanaan is currently accepting new patients.

Lubomir Sokol is a Hematologist and an Oncologist practicing medicine in Tampa, Florida. Dr. Sokol is highly rated in 55 conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Sokol is currently accepting new patients.

Deepika Darbari, MD, is a hematologist at Children's National in the Center for Cancer and Blood Disorders. Dr. Darbari is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, Hemoglobinopathy, and Bone Marrow Transplant. Dr. Darbari is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2013 and Pediatrics: American Board Of Pediatrics, 1998. Dr. Darbari is currently accepting new patients.

Dr. Lydia H. Pecker is a pediatric hematologist and Director of the Young Adult Clinic at the Sickle Cell Center for Adults at Johns Hopkins. Dr. Pecker received her undergraduate degree in Africana studies from Brown University and earned her M.D. at the University of Pennsylvania School of Medicine. She completed residency training at Children’s Hospital at Montefiore and completed a fellowship at Children’s National Medical Center and the National Institutes of Health’s National Heart, Lung and Blood Institute before joining the Hopkins faculty in 2016. Dr. Pecker's NIH and foundation-funded research focuses on reproductive health in people with ovaries and sickle cell disease. Dr. Pecker is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Tubal Ligation, and Bone Marrow Transplant. Dr. Pecker is board certified in American Board Of Pediatrics. Dr. Pecker is currently accepting new patients.

Emily Meier is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Meier is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Transplant. Dr. Meier is currently accepting new patients.

Steven Pavletic is a Hematologist and an Oncologist practicing medicine in Bethesda, Maryland. Dr. Pavletic is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Graft.

Geoffrey Gibney is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Gibney is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Olfactory Neuroblastoma, and Sinus Cancer. Dr. Gibney is currently accepting new patients.

As a doctor who diagnoses and treats cancer, medicine is a calling for me. I strive to always provide the highest quality of care to my patients. I strongly believe that every patient needs to be treated as a whole, and it is critical for me to understand each and every one of my patients’ backgrounds and needs. I also have a strong interest in clinical trials. There have been many exciting therapies in the field of hematology/oncology – the field of medicine focusing on cancer diagnosis and treatment. But more research still needs to be done to keep improving upon the standard of care. Dr. Ruan is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Reticulohistiocytoma, Histiocytosis, Rosai-Dorfman Disease, Non-Langerhans-Cell Histiocytosis, and Bone Marrow Aspiration. Dr. Ruan is board certified in American Board Of Internal Medicine-Medical Oncology, American Board Of Internal Medicine-Hematology, and American Board Of Internal Medicine. Dr. Ruan is currently accepting new patients.

Jijun Liu is a Hematologist and an Oncologist practicing medicine in Peoria, Illinois. Dr. Liu is highly rated in 105 conditions, according to our data. Her clinical expertise encompasses Severe Congenital Neutropenia, Lung Cancer, Pleuropulmonary Blastoma, Chronic Familial Neutropenia, and Bone Marrow Aspiration. Dr. Liu is board certified in American Board Of Internal Medicine. Dr. Liu is currently accepting new patients.

Dr. Jeffrey L. Wolf is a hematologist with expertise in cancers of the bone marrow and blood, as well as in bone marrow transplantation to treat these cancers. His primary focus in both patient care and research is myeloma, the second most common blood cancer. He directs UCSF's Multiple Myeloma Program and the Stephen and Nancy Grand Multiple Myeloma Translational Initiative – a program to support the development of better treatments – at the UCSF Helen Diller Family Comprehensive Cancer Center. Wolf's current research interests are in measuring minimal residual disease in patients who have undergone successful treatment for myeloma, as the results are useful in predicting long-term survival. Wolf earned his medical degree at the University of Illinois College of Medicine at Chicago and completed a residency in medicine at the University of California, San Diego. He completed a fellowship in hematology and oncology at UCSF, followed by a bone marrow transplantation rotation at the Fred Hutchinson Cancer Research Center. In 1979, Wolf helped establish the bone marrow transplant program at the City of Hope Comprehensive Cancer Center in Duarte, California. In 1984, he helped establish the first bone marrow transplant unit based at a community hospital in the United States, at Alta Bates Summit Medical Center in Berkeley. He joined UCSF in 2007. Dr. Wolf is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Wolf is board certified in American Board Of Internal Medicine/Hematology, Hematology and American Board Of Internal Medicine, Internal Medicine. Dr. Wolf is currently accepting new patients.

Pauline Funchain is a Hematologist and an Oncologist practicing medicine in Cleveland, Ohio. Dr. Funchain is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Metastatic Uveal Melanoma, Melanoma of the Eye, and Endoscopy.

Dr. Thomas Buroker completed his undergraduate work at The University of Iowa where he graduated in 1964. He went on to graduate from the College of Osteopathy Medical and Surgery (now the Des Moines University). Dr. Buroker completed a residency at the Grace Hospital in Detroit. He completed a fellowship in Medical Oncology at Wayne State University Medical School in Detroit. Dr. Buroker is highly rated in 105 conditions, according to our data. His clinical expertise encompasses Severe Congenital Neutropenia, Lung Cancer, Pleuropulmonary Blastoma, Bone Marrow Aspiration, and Gastrostomy. Dr. Buroker is currently accepting new patients.

Douglas Harrison is a Hematologist and an Oncologist practicing medicine in Wilmington, Delaware. Dr. Harrison is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Rhabdomyosarcoma, Adult Soft Tissue Sarcoma, Osteosarcoma, and Ewing Sarcoma. Dr. Harrison is board certified in American Board Of Pediatrics. Dr. Harrison is currently accepting new patients.

Michael Heinrich is a Hematologist practicing medicine in Portland, Oregon. Dr. Heinrich is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Childhood Acute Myeloid Leukemia, and Leukemia. Dr. Heinrich is currently accepting new patients.

Anup Lal is a Hematologist and an Oncologist practicing medicine in Port Huron, Michigan. Dr. Lal is highly rated in 55 conditions, according to our data. His clinical expertise encompasses Transient Erythroblastopenia of Childhood, Pure Red Cell Aplasia, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Bone Marrow Aspiration. Dr. Lal is board certified in American Board Of Internal Medicine. Dr. Lal is currently accepting new patients.

Drew Dill is a Hematologist Oncology specialist and a Hematologist practicing medicine in Collierville, Tennessee. Dr. Dill is highly rated in 55 conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Inflammatory Breast Cancer, Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, and Bone Marrow Aspiration. Dr. Dill is currently accepting new patients.